Heavy Cannabis Use Linked to CVD Mortality in Women
By Elana Gotkine HealthDay Reporter
THURSDAY, June 6, 2024 -- Heavy cannabis use is associated with a significantly increased risk for cardiovascular disease (CVD) mortality among women, according to a study published online June 6 in JAMA Network Open.
Alexandre Vallée, M.D., Ph.D., from Foch Hospital in Suresnes, France, examined sex-stratified associations of cumulative lifetime cannabis use with all-cause, CVD, and cancer mortality using data from volunteers in the U.K. Biobank population. Data were included for 121,895 participants.
During a median follow-up of 11.80 years, Vallée identified 2,375 total deaths, including 1,411 and 440 deaths from CVD and cancer, respectively. After full adjustment, in men, the hazard ratios (95 percent confidence intervals) were 1.28 (0.90 to 1.81), 0.98 (0.43 to 2.25), and 1.09 (0.71 to 1.67) for all-cause mortality, CVD mortality, and cancer mortality, respectively, for heavy cannabis users versus nonusers. In women, the corresponding hazard ratios (95 percent confidence intervals) after full adjustment were 1.49 (0.92 to 2.40), 2.67 (1.19 to 4.32), and 1.61 (0.91 to 2.83) among heavy cannabis users versus nonusers. Heavy cannabis use was associated with a significantly increased risk for all-cause mortality, CVD mortality, and cancer mortality in female current tobacco users and with CVD mortality among female never tobacco users, after full adjustment. Heavy cannabis use was associated with a significantly increased risk for cancer mortality in male current tobacco users.
"Individuals using cannabis should be considered for appropriate cardiovascular risk-reduction strategies, especially among females," Vallée writes.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2024
Read this next
Familial Recurrence Rate of Autism Spectrum Disorder 20.2 Percent
WEDNESDAY, July 17, 2024 -- The familial recurrence rate of autism spectrum disorder (ASD) is 20.2 percent, which has not changed significantly from previous estimates, according...
Aging Into Medicare Tied to Higher Drug Costs for People With Diabetes
WEDNESDAY, July 17, 2024 -- As people with diabetes age into Medicare, they face increased quarterly out-of-pocket costs for medication, according to a study published online July...
Race, Ethnic Disparities Seen in Age-Adjusted Prevalence of Arthritis
WEDNESDAY, July 17, 2024 -- The age-adjusted prevalence of arthritis varies by race and ethnicity, with higher prevalence seen among American Indian/Alaska Native adults...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.